FEBRILE BONE MARROW APLASIA side effect
What is FEBRILE BONE MARROW APLASIA ?Drugs associated with FEBRILE BONE MARROW APLASIA
ADVIL AVASTIN BEVACIZUMAB BICNU CAMPATH CETUXIMAB CISPLATIN CYTARABINE DEPOCYT ENDOXAN LYSODREN NAVELBINE NEULASTA RITUXIMAB SUTENT TEMODAL VELCADE ZOFRANFEBRILE BONE MARROW APLASIA : Rituximab Side Effects Report #5655961-X
Consumer or non-health professional from UNITED KINGDOM reported RITUXIMAB problem on Feb 25, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, . RITUXIMAB dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Bevacizumab Side Effects Report #5660821-4
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Feb 05, 2008. Female patient, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . BEVACIZUMAB dosage: 1020 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, INIPOMP, STILNOX, LEXOMIL, DOMPERIDONE, COLPOTROPHINE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Rituximab Side Effects Report #5677820-9
Consumer or non-health professional from UNITED KINGDOM reported RITUXIMAB problem on Mar 11, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, . RITUXIMAB dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Campath Side Effects Report #5639630-8
CAMPATH problem was reported by a Health Professional from FRANCE on Feb 12, 2008. Male patient, 19 years of age, was diagnosed with lymphoproliferative disorder and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, pancytopenia, . CAMPATH dosage: TOTAL DAILY DOSE: 3 MG. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Rituximab Side Effects Report #5548338-9
Physician from UNITED KINGDOM reported RITUXIMAB problem on Dec 03, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Rituximab Side Effects Report #5548343-2
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Dec 03, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, PANADO. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Temodal Side Effects Report #5558013-2
Physician from FRANCE reported TEMODAL problem on Dec 04, 2007. Female patient, 73 years of age, weighting 143.3 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, haematotoxicity, hypokalaemia, . TEMODAL dosage: 150 MG/M2;QD;PO; 340 MG;QD;PO. During the same period patient was treated with LEVOTHYROX, PANTOPRAZOLEE, RYTHMOL, INDAPAMIDE, TANAKAN, ZOPICLONE, DIAMICRON. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Advil Side Effects Report #5518033-0
ADVIL problem was reported by a Health Professional from FRANCE on Nov 07, 2007. Male patient was diagnosed with teething, pyrexia and was treated with ADVIL. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, granulocytes maturation arrest, . ADVIL dosage: unknown. During the same period patient was treated with ZYMAFLUOR, TAZOCILLINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Endoxan Side Effects Report #5520143-9
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 05, 2007. Male patient, 62 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, MABTHERA, VINCRISTINE, CORTANCYL. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Cisplatin Side Effects Report #5479582-7
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2007. Male patient, 57 years of age, weighting 90.39 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . CISPLATIN dosage: unknown. During the same period patient was treated with NEULASTA, FLUOROURACIL, EPIRUBICIN. Patient was hospitalized. Patient died on 03/23/2007.
FEBRILE BONE MARROW APLASIA : Cisplatin Side Effects Report #5485368-X
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Oct 03, 2007. Male patient, 57 years of age, weighting 90.39 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, malignant neoplasm progression, neutropenia, thrombocytopenia, . CISPLATIN dosage: unknown. During the same period patient was treated with NEULASTA, FLUOROURACIL, EPIRUBICIN. Patient was hospitalized. Patient died on 03/23/2007.
FEBRILE BONE MARROW APLASIA : Bevacizumab Side Effects Report #5452655-0
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Aug 30, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . BEVACIZUMAB dosage: 1020 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, INIPOMP, STILNOX, LEXOMIL, COLPOTROPHINE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Bicnu Side Effects Report #5405253-9
Health Professional from FRANCE reported BICNU problem on Aug 02, 2007. Female patient, 15 years of age, was diagnosed with hodgkin's disease stage iii and was treated with BICNU. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, mucosal inflammation, . BICNU dosage: unknown. During the same period patient was treated with VINDESINE, ADRIAMYCIN PFS, ETOPOSIDE, METHYLPREDNISOLONE, ZOFRAN, LARGACTIL, BACTRIM. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Endoxan Side Effects Report #5415725-9
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Female patient, 59 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, . ENDOXAN dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN HYDROCHLORIDE, CORTANCYL, RITUXAN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Neulasta Side Effects Report #5398984-0
Physician from FRANCE reported NEULASTA problem on July 16, 2007. Male patient, weighting 90.39 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . NEULASTA dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CISPLATIN. Patient was hospitalized. Patient died on 03/23/2007.
FEBRILE BONE MARROW APLASIA : Neulasta Side Effects Report #5398984-0
NEULASTA problem was reported by a Physician from FRANCE on July 16, 2007. Male patient, weighting 90.39 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . NEULASTA dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CISPLATIN. Patient was hospitalized. Patient died on 03/23/2007.
FEBRILE BONE MARROW APLASIA : Temodal Side Effects Report #5676575-1
Physician from FRANCE reported TEMODAL problem on Mar 11, 2008. Female patient, 73 years of age, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile bone marrow aplasia, haematotoxicity, hypokalaemia, mouth haemorrhage, oropharyngeal blistering, purpura, . TEMODAL dosage: 150 MG/M2 QD PO ; 340 MG QD PO ; 255 MG QD PO ; PO. During the same period patient was treated with LEVOTHYROXINE, PANTOPRAZOLE, RYTHMOL, INDAPAMIDE, TANAKAN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Navelbine Side Effects Report #5683442-6
NAVELBINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 14, 2008. Male patient was diagnosed with sarcoma, hiv infection and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, febrile neutropenia, . NAVELBINE dosage: 47 MG QD IV. During the same period patient was treated with ANTIPROTEASE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Depocyt Side Effects Report #5608251-5
Physician from FRANCE reported DEPOCYT problem on Jan 10, 2008. Female patient, 73 years of age, was diagnosed with acute myeloid leukaemia, central nervous system leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, febrile bone marrow aplasia, . DEPOCYT dosage: 50 MG; QOW; INTH. During the same period patient was treated with METHOTREXATE, CYTARABINE, CORTICOSTEROIDS, AZACITIDINE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Lysodren Side Effects Report #5509019-0
LYSODREN problem was reported by a Health Professional from FRANCE on Oct 29, 2007. Female patient, 59 years of age, was diagnosed with adrenocortical carcinoma and was treated with LYSODREN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile bone marrow aplasia, . LYSODREN dosage: unknown. During the same period patient was treated with CISPLATIN, DOXORUBICIN, VEPESID. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Zofran Side Effects Report #5512916-3
Consumer or non-health professional from FRANCE reported ZOFRAN problem on Oct 31, 2007. Male patient, 67 years of age, was diagnosed with laryngeal cancer and was treated with ZOFRAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile bone marrow aplasia, radiation mucositis, . ZOFRAN dosage: 8MG PER DAY. During the same period patient was treated with TAXOTERE, CISPLATIN, FLUOROURACIL, PLITICAN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Endoxan Side Effects Report #5519442-6
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 05, 2007. Male patient, 57 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: anorexia, febrile bone marrow aplasia, mucosal inflammation, . ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, BLEOMYCIN, MABTHERA, ELDISINE, CORTANCYL. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Endoxan Side Effects Report #5474433-9
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Sept 21, 2007. Female patient, 67 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, lung disorder, . ENDOXAN dosage: unknown. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient died on 07/26/2007.
FEBRILE BONE MARROW APLASIA : Avastin Side Effects Report #5477376-X
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Sept 19, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, febrile bone marrow aplasia, hepatic failure, . AVASTIN dosage: 10 MG/KG, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Cetuximab Side Effects Report #5479841-8
Health Professional from GERMANY reported CETUXIMAB problem on Sept 24, 2007. Female patient, 46 years of age, was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile bone marrow aplasia, pain, renal failure, thrombocytopenia, . CETUXIMAB dosage: ,250 MG/M2 MOST RECENT INFUSION 23JUL2007. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Cetuximab Side Effects Report #5481665-2
CETUXIMAB problem was reported by a Health Professional from GERMANY on Sept 21, 2007. Female patient, 70 years of age, was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile bone marrow aplasia, thrombocytopenia, . CETUXIMAB dosage: 400 MG/M2 WAS ADMINISTERED ONCE FROM 28-JUN-2007. During the same period patient was treated with CISPLATIN, HYCAMTIN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Velcade Side Effects Report #5483861-7
Physician from FRANCE reported VELCADE problem on Sept 25, 2007. Male patient, 51 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, febrile bone marrow aplasia, . VELCADE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN, ALKERAN. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Sutent Side Effects Report #5460643-3
SUTENT problem was reported by a Physician from FRANCE on Sept 07, 2007. Male patient, 57 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: asthenia, febrile bone marrow aplasia, neutropenia, thrombocytopenia, . SUTENT dosage: unknown. Patient recovered.
FEBRILE BONE MARROW APLASIA : Bevacizumab Side Effects Report #5377473-3
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on June 20, 2007. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile bone marrow aplasia, jaundice, pyrexia, . BEVACIZUMAB dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, VINORELBINE, FENTANYL, FORLAX, ACTISKENAN, NEXIUM, LEXOMIL. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Bevacizumab Side Effects Report #5377473-3
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 20, 2007. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile bone marrow aplasia, jaundice, pyrexia, . BEVACIZUMAB dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, VINORELBINE, FENTANYL, FORLAX, ACTISKENAN, NEXIUM, LEXOMIL. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Navelbine Side Effects Report #5500268-4
Consumer or non-health professional from FRANCE reported NAVELBINE problem on July 02, 2007. Male patient, 59 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: anisocytosis, cardiac failure, febrile bone marrow aplasia, red blood cell abnormality, . NAVELBINE dosage: unknown. During the same period patient was treated with PARAPLATIN, SKENAN, SEVREDOL, LASIX, DAFALGAN, CORDARONE, IMOVANE, DUPHALAC. Patient was hospitalized. Patient died on 01/26/2005.
FEBRILE BONE MARROW APLASIA : Velcade Side Effects Report #5455053-9
VELCADE problem was reported by a Physician from FRANCE on May 02, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anaemia, chills, febrile bone marrow aplasia, productive cough, tachycardia, tachypnoea, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
FEBRILE BONE MARROW APLASIA : Cytarabine Side Effects Report #5470330-3
Health Professional from UNITED STATES reported CYTARABINE problem on Sept 17, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, disseminated intravascular coagulation, febrile bone marrow aplasia, febrile neutropenia, hepatic candidiasis, hepatic lesion, liver abscess, sepsis, . CYTARABINE dosage: 20 MG/M2 PER_CYCLE IV. Patient was hospitalized. Patient died on 01/02/2006.
FEBRILE BONE MARROW APLASIA : Velcade Side Effects Report #5424517-6
VELCADE problem was reported by a Physician from FRANCE on Aug 13, 2007. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, diarrhoea, febrile bone marrow aplasia, febrile neutropenia, haemoglobin decreased, hypocalcaemia, hypomagnesaemia, hyponatraemia, mucosal inflammation, . VELCADE dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with BLEOMYCIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, ELDISINE, PREDNISONE, GRANOCYTE. Patient was hospitalized. Patient recovered.